Hydromorphone Kalceks (Hydromorphone Hydrochloride)

Hydromorphone is an opioid analgesic used in the management of pain conditions that require potent mu‑opioid receptor activation.

• Severe acute pain: provides rapid relief of intense pain episodes.
• Post‑operative pain: helps control pain following surgical procedures.
• Traumatic injury pain: alleviates severe pain from major injuries.

• Hydromorphone acts as a full agonist at central mu‑opioid receptors, triggering inhibitory G‑protein pathways that decrease neuronal excitability and reduce the release of pain‑transmitting neurotransmitters. This results in diminished perception of pain and increased sedation, while also affecting respiratory drive and gastrointestinal motility.

Hydromorphone may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness.
• Sweating: excessive perspiration.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be fatal.
• Severe hypotension: marked drop in blood pressure.
• Addiction or dependence: compulsive use despite harm.
• Anaphylactic reaction: severe allergic response with hives, swelling, or airway compromise.
• Adrenal insufficiency: rare hormonal deficiency affecting stress response.

When prescribing or handling Hydromorphone, several safety measures should be observed.

• Assess pain severity: confirm that opioid therapy is appropriate.
• Monitor respiratory function: watch for signs of depression, especially after dose changes.
• Use lowest effective dose: titrate to achieve analgesia while minimizing risk.
• Avoid in patients with severe respiratory depression: contraindicated in uncontrolled breathing disorders.
• Caution in renal or hepatic impairment: adjust dosing and monitor closely.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Hydromorphone can interact with other medicines, altering its effects or increasing safety risks.

Major Interactions (Avoid)

• Other central nervous system depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): can precipitate severe hypotension or serotonin syndrome.
• Concurrent opioid therapy: increases risk of overdose and respiratory compromise.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise hydromorphone plasma levels.
• Antihistamines (e.g., diphenhydramine): can enhance sedation and dizziness.
• Diuretics (e.g., furosemide): may potentiate hypotensive effects.